Fertility preservation after gonadotoxic treatments for cancer and autoimmune diseases

BACKGROUND: The indications for fertility preservation (FP) have expanded. A few patients who underwent gonadotoxic treatment did not have the opportunity to receive FP, leading to concerns that these patients may develop premature ovarian insufficiency. However, the usefulness of FP in women with r...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Saki, Yamada, Mitsutoshi, Yano, Rika, Takahashi, Kazuko, Ebara, Akiko, Sakanaka, Hiroe, Matsumoto, Miho, Ishimaru, Tomoko, Utsuno, Hiroki, Matsuzawa, Yuichi, Ooka, Reina, Fukuoka, Mio, Akashi, Kazuhiro, Kamijo, Shintaro, Hamatani, Toshio, Tanaka, Mamoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416401/
https://www.ncbi.nlm.nih.gov/pubmed/37563616
http://dx.doi.org/10.1186/s13048-023-01250-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416401/
https://www.ncbi.nlm.nih.gov/pubmed/37563616
http://dx.doi.org/10.1186/s13048-023-01250-x

Ejemplares similares